How this year’s Medicare drug price negotiations could affect the pharmaceutical industry.
Insights
Strong performance from Japanese larger companies is setting the scene for small and mid-cap stocks to shine given their potential for relatively higher growth.
The drivers of emerging market equity returns are evolving as innovation and economic decoupling join favorable demographics as future sources of excess returns.
This week's chart to watch spotlights the contrast between U.S. rate cut expectations and the broad economic growth trajectory.
Global dividends rose to a record US$606.1 billion, up 8.2% on an underlying basis.
Our latest Investor Survey reveals high levels of concern around financial exploitation, particularly as AI leads to increasingly sophisticated scams.
Why investors looking to diversify equity portfolios may want to consider these long-discounted financials.
Hear how AI and other advances in healthcare are transforming patient outcomes and leading to new investment opportunities.
Signals embedded in options markets indicate a closer race for the White House than suggested by consensus polling data.
After years of underperformance, non-U.S. equity markets look poised for better returns.
Why we believe the strategic case for AAA CLOs remains compelling amid Fed rate cuts.